Amer A Amer

This inventor holds 169 USPTO granted patents and 4 published patent applications, primarily in Antimicrobial Compounds (CPC class A61P31-04). Top assignee: King Faisal University. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amer A Amer. Retrieved from https://idiyas.com/inventor/amer-a-amer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 169 (Patent Applications = 4)

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 17(Granted Patents)

Forward Citations (Not Self Cited) = 1(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

169 out of 820

King Faisal University

patents

Years Active: 2023-2025

Loading Chart...

Areas of Expertise:

Antimicrobial

Antioxidant

Anti-Cancer

Inflammatory

Thiadiazole

Imidazole

Oxadiazole

Phenyl

Naphthalene

Benzothiazole

Benzoxazole

Chlorophenyl

169 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264128 - Acid as an antioxidant compound (2025-04-01),

2. 12264127 - 8-((3-formyl-4-hydroxyphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound (2025-04-01),

3. 12195430 - 6-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)hexanoic acid as an antimicrobial compound (2025-01-14),

4. 12187718 - 1-cyclopropyl-6-fluoro-7-(4-((5-(4-methoxybenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound (2025-01-07),

5. 12180204 - 2-(benzo[d]thiazol-2-yl)-N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound (2024-12-31),

6. 12180203 - 2-(benzo[d]thiazol-2-yl)-n'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound (2024-12-31),

7. 12180202 - 2-[(1,3-benzothiazol-2-yl)imino]-5,5-diphenylimidazolidin-4-one as an antimicrobial compound (2024-12-31),

8. 12180201 - 2-(benzo[d]oxazol-2-yl)-N'-(isonicotinoyloxy)acetimidamide as an antimicrobial compound (2024-12-31),

9. 12180200 - 2-(benzo[d]oxazol-2-yl)-n'-(isonicotinoyloxy)acetimidamide as an antimicrobial compound (2024-12-31),

10. 12180199 - 2-(benzo[d]oxazol-2-yl)-n'-(isonicotinoyloxy)acetimidamide as an antimicrobial compound (2024-12-31),

11. 12180195 - 6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(2,4-dichlorophenyl)-2-alkoxynicotinonitrile as an antimicrobial compound (2024-12-31),

12. 12180173 - 5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound (2024-12-31),

13. 12180172 - [3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound (2024-12-31),

14. 12180171 - N'-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound (2024-12-31),

15. 12180170 - 2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetic acid as an antimicrobial compound (2024-12-31),

Title:

Inventor Amer A Amer: Revolutionizing Innovation from Sohag, EG

Introduction:

Amer A Amer, a brilliant inventor hailing from Sohag, Egypt, is making waves in the world of innovation with his groundbreaking ideas and creations. His passion for pushing the boundaries of what is possible has led to numerous patents and advancements in various fields.

Latest Patents:

Amer A Amer's latest patents showcase his ingenuity and forward-thinking approach to problem-solving. His inventions have ranged from technological solutions to everyday challenges, each patent a testament to his creativity and dedication.

Career Highlights:

Throughout his illustrious career, Amer A Amer has consistently demonstrated his ability to innovate and create solutions that have a lasting impact. His work has not only earned him recognition in the industry but has also improved the lives of many through his inventions.

Collaborations:

Amer A Amer's collaborative spirit has led to fruitful partnerships with other innovators,

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents pending: